Cargando…
Preventive Efficacy and Safety of Rebamipide in Nonsteroidal Anti-Inflammatory Drug-Induced Mucosal Toxicity
BACKGROUND/AIMS: The use of proton pump inhibitors or misoprostol is known to prevent the gastrointestinal complications of nonsteroidal anti-inflammatory drugs (NSAIDs). Rebamipide is known to increase the mucosal generation of prostaglandins and to eliminate free oxygen radicals, thus enhancing th...
Autores principales: | Kim, Jeong Ho, Park, Soo-Heon, Cho, Chul-Soo, Lee, Soo Teik, Yoo, Wan-Hee, Kim, Sung Kook, Kang, Young Mo, Rew, Jong Sun, Park, Yong-Wook, Lee, Soo Kon, Lee, Yong Chan, Park, Won, Lee, Don-Haeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Gut and Liver
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113040/ https://www.ncbi.nlm.nih.gov/pubmed/25071901 http://dx.doi.org/10.5009/gnl.2014.8.4.371 |
Ejemplares similares
-
The Toxicity of Nonsteroidal Anti-inflammatory Eye Drops against Human Corneal Epithelial Cells in Vitro
por: Lee, Jong Soo, et al.
Publicado: (2015) -
Efficacy and Safety of Rebamipide versus Its New Formulation, AD-203, in Patients with Erosive Gastritis: A Randomized, Double-Blind, Active Control, Noninferiority, Multicenter, Phase 3 Study
por: Kim, Gwang Ha, et al.
Publicado: (2021) -
The Benefits of Combination Therapy with Esomeprazole and Rebamipide in Symptom Improvement in Reflux Esophagitis: An International Multicenter Study
por: Hong, Su Jin, et al.
Publicado: (2016) -
The effect of rebamipide on non-steroidal antiinflammatory drug-induced gastro-enteropathy: a multi-center, randomized pilot study
por: Oh, Dong Jun, et al.
Publicado: (2022) -
Comparison of Prevention of NSAID-Induced Gastrointestinal Complications by Rebamipide and Misoprostol: A Randomized, Multicenter, Controlled Trial—STORM STUDY
por: Park, Soo-Heon, et al.
Publicado: (2007)